<DOC>
	<DOCNO>NCT01049984</DOCNO>
	<brief_summary>To assess efficacy rasagiline 1 mg first add-on treatment dopamine agonist therapy early Parkinson Disease ( PD ) patient , , optimally control dopamine agonist compare placebo .</brief_summary>
	<brief_title>Rasagiline Add Dopamine Agonists Treatment Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Dopamine Agonists</mesh_term>
	<criteria>receive stable dose oral ropinirole pramipexole whose symptom optimally control whose oral dopamine agonist titration regimen truncate due intolerability : 1 ) Minimum dose agonist 6 mg/day ropinirole 1.0 mg/day pramipexole 2 ) Stable dopamine agonist treatment must ongoing ≥ 30 day , long 5 year precede baseline Males female . Women childbearing potential must agree practice acceptable method birth control . Idiopathic Parkinson Disease confirm baseline presence least 2 cardinal sign ( rest tremor , bradykinesia , rigidity ) , w/o know suspected cause Parkinsonism Hoehn &amp; Yahr &gt; 1 ( symptom one side body ) treatment &lt; 3 ( mild moderate bilateral disease ; postural instability ; physically independent ) . Dopamine agonist dose must stable ≥30 day precede baseline visit . For patient receive amantadine anticholinergic , dose must stable ≥30 day prior screen . Medically stable outpatient ( Investigator 's judgment ) . receive rasagiline monoamine oxidase ( MAO ) inhibitor 60 day precede baseline receive levodopa &gt; 21 consecutive day within 90 day prior baseline moderate severe motor fluctuation hepatic impairment investigational medication 30 day precede baseline dopamine agonist use &gt; 5 year prior baseline major depression define Beck Depression Inventory ( BDI ) short form score great 14 significant cognitive impairment define MiniMental State Exam ( MMSE ) score less 26. impulse control disorder ( ICD ) base Questionnaire Impulsivecompulsive Disorders Parkinson 's Disease form ( QUIP ) . pregnant lactate plan become pregnant next 18 week uncontrolled hypertension . Patients whose hypertension control medication eligible . Concomitant monoamine oxidase ( MAO ) inhibitor medicine contraindicate w/ MAO inhibitor allow</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>UPDRS</keyword>
	<keyword>Clinical Global Evaluation Illness Severity score</keyword>
	<keyword>Clinical Global Evaluation Improvement</keyword>
	<keyword>B-SIT</keyword>
	<keyword>SCOPA - Sleep Daytime Sleepiness</keyword>
	<keyword>PDQ -39</keyword>
	<keyword>SCOPA - Cognition</keyword>
	<keyword>Levodopa</keyword>
	<keyword>rasagiline</keyword>
	<keyword>Dopamine Agonist Therapy</keyword>
	<keyword>monoamine oxidase type B inhibitor</keyword>
</DOC>